Prediction Markets Push Into US Stocks: Regulators Raise Alarm

·
Listen to this article~4 min

Prediction markets are expanding into US stocks, raising concerns about insider trading and regulation. Here's what traders need to know about this risky new frontier.

### The Sudden Move Into Wall Street Prediction markets are making a bold move into US stocks, and regulators are not happy about it. These platforms, which let people bet on everything from elections to economic data, are now offering contracts tied to stock prices. That's a big shift. It blurs the line between gambling and investing, and it's catching the attention of watchdogs in Washington. The core issue? If you can bet on whether Apple's stock will hit $200 by June, you're basically trading a derivative. But prediction markets aren't regulated like stock exchanges. They operate in a gray area, often under the oversight of the Commodity Futures Trading Commission (CFTC). That's a recipe for confusion—and potential abuse. ### Why Regulators Are Worried First, there's the risk of insider trading. If someone knows a company is about to announce bad earnings, they could bet against its stock on a prediction market. That's illegal in traditional markets, but prediction markets don't have the same safeguards. The CFTC has rules against fraud and manipulation, but enforcement is tricky. Second, these markets could become a backdoor for speculative frenzy. Imagine a platform where you can bet on Tesla's stock price with 100x leverage. That's not investing; it's gambling. And when things go wrong, retail traders could lose big. > "Prediction markets are a fascinating experiment in collective intelligence, but when they touch regulated securities, the guardrails matter," says one former CFTC official. "We can't let them become a shadow stock market." ### What's Actually Happening Several prediction market platforms have recently launched or announced plans to offer contracts on US equities. Kalshi, a CFTC-regulated exchange, has been pushing boundaries. Others, like Polymarket, operate offshore and aren't available to US users—but that hasn't stopped speculation. The push comes as prediction markets gain mainstream traction. During the 2024 election cycle, billions of dollars flowed into political bets. Now, these platforms want to expand into financial markets. But unlike elections, stock prices are already heavily regulated. The SEC and CFTC are watching closely. - **Kalshi** has filed to offer contracts on major indices like the S&P 500. - **Polymarket** remains offshore but is eyeing US re-entry. - **PredictIt** shut down its US operations after a court ruling. The regulatory patchwork is a mess. Some markets are legal, some aren't. And the rules change depending on which agency is in charge. ### The Insider Trading Question Insider trading is the elephant in the room. In traditional markets, insider trading is illegal because it undermines fairness. If you have material non-public information, you can't trade on it. But prediction markets don't have the same explicit prohibition. That's a loophole. Suppose a corporate executive knows their company will miss earnings. They could bet on a prediction market that the stock will fall. That's insider trading, but proving it is hard. The CFTC has brought cases, but they're rare. And without clear rules, bad actors might exploit the gap. ### What This Means for Traders If you're a retail trader, this could be a double-edged sword. On one hand, prediction markets offer a new way to hedge or speculate. On the other, they're risky. Liquidity can be thin, and prices can be manipulated. Plus, if regulators crack down, your positions could be frozen. For now, the smart move is caution. Don't treat prediction markets like a stock exchange. They're not. And if you're betting on stocks, make sure you understand the rules—or lack thereof. ### The Bottom Line Prediction markets are pushing into US stocks, and regulators are scrambling to respond. The outcome will shape how these platforms evolve. Will they become a legitimate financial tool, or a regulatory headache? Only time will tell. But one thing's clear: the days of operating in the shadows are numbered.